Title 21 Definitions Flashcards
Act
Federal food drug and cosmetic act
Agency
Food and Drug Administration
Biometrics
Verifying and measuring an individuals identity based on physical features/ repeatable actions specific to that individual
Closed System
Environment in which system access is controlled by persons who are responsible for the content of electronic records that are on the system
Digital Signature
Electronic Signature based upon any photographic methods of originator authentication computed by using a set of rules and a set of parameters such that identity of signer and integrity of data can be verified
Electronic Record
Combination of text graphics, data, audio, pictorial, other information, representation, in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system
Electronic Signature
Computer data compilation of any symbol or series of symbols executed, adopted, or authorized by an individual to be legally binding equivalent for individuals handwritten signature
Handwritten Signature
Scripted name or legal mark of an individual handwritten by that individual and executed or adopted with the present intention to authenticate a writing in a permanent form
Open System
Environment in which system access is not controlled by persons who are responsible for the content of electronic records that are on the system
Clinical Investigation
Experiment with test article, one or more human subjects, and subject to submission for FDA(either prior or after for inspection)
Investigator
Individual conducting clinical investigation
- usually under their immediate direction test article is administered, dispensed to subject
- when team is involved, they are responsible leader of the team
Sponsor
Person who initiates but does not conduct clinical investigation
*a person other than a individual (corporation or agency) that uses employees to conduct clinical investigation
Emergency Use
Use of a test article on a human when
- in life threatening situation
- no standard acceptable treatment is available
- no sufficient time to obtain IRB
Human Subject
Individual who is or becomes a participant in research as recipient of test article or control
Institution
Public or private entity or agency (federal, state, or other agencies) synonymous with facility